Abstract
Elastin-associated vasculopathies are life-threatening conditions of blood vessel dysfunction. The extracellular matrix protein elastin endows the recoil and compliance required for physiologic arterial function, while disruption of function can lead to aberrant vascular smooth muscle cell proliferation manifesting through stenosis, aneurysm, or vessel dissection. Although research efforts have been informative, they remain incomplete as no viable therapies exist outside of a heart transplant. Induced pluripotent stem cell technology may be uniquely suited to address current obstacles as these present a replenishable supply of patient-specific material with which to study disease. The following review will cover the cutting edge in vascular smooth muscle cell modeling of elastin-associated vasculopathy, and aid in the development of human disease modeling and drug screening approaches to identify potential treatments. Vascular proliferative disease can affect up to 50% of the population throughout the world, making this a relevant and critical area of research for therapeutic development.
Similar content being viewed by others
Abbreviations
- VSMC:
-
Vascular smooth muscle cell
References
Christiano AM, Uitto J (1994) Molecular pathology of the elastic fibers. J Investig Dermatol 103(5, Supplement):S53–S57
Holst J et al (2010) Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat Biotechnol 28:1123
Liu S-L et al (2015) Matrix metalloproteinase-12 is an essential mediator of acute and chronic arterial stiffening. Sci Rep 5:17189
Parks WC et al (1988) Developmental regulation of tropoelastin isoforms. J Biol Chem 263(9):4416–4423
Swee MH, Parks WC, Pierce RA (1995) Developmental regulation of elastin production: expression of tropoelastin pre-mRNA persists after down-regulation of steady-state mRNA levels. J Biol Chem 270(25):14899–14906
Sakai LY, Keene DR, Engvall E (1986) Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103(6):2499
Trask TM et al (2000) Interaction of tropoelastin with the amino-terminal domains of fibrillin-1 and fibrillin-2 suggests a role for the fibrillins in elastic fiber assembly. J Biol Chem 275(32):24400–24406
Pfaff M et al (1996) Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett 384(3):247–250
Tiedemann K et al (2001) Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assembly. J Biol Chem 276(38):36035–36042
Yanagisawa H et al (2002) Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415:168
Ge X et al (2012) Modeling supravalvular aortic stenosis syndrome using human induced pluripotent stem cells. Circulation 126(14):1695–1704
Karnik SK et al (2003) A critical role for elastin signaling in vascular morphogenesis and disease. Development 130(2):411
Karnik SK et al (2003) Elastin induces myofibrillogenesis via a specific domain, VGVAPG. Matrix Biol 22(5):409–425
Lee P et al (2014) A novel cell adhesion region in tropoelastin mediates attachment to integrin αVβ5. J Biol Chem 289(3):1467–1477
Misra A et al (2016) Integrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis. J Exp Med 213(3):451–463
Wilson BD et al (2011) Novel approach for endothelializing vascular devices: understanding and exploiting elastin-endothelial interactions. Ann Biomed Eng 39(1):337–346
Broekelmann TJ et al (2005) Tropoelastin interacts with cell-surface glycosaminoglycans via its COOH-terminal domain. J Biol Chem 280(49):40939–40947
Mochizuki S, Brassart B, Hinek A (2002) Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem 277(47):44854–44863
Cordes KR et al (2009) miR-145 and miR-143 regulate smooth muscle cell fate decisions. Nature 460(7256):705–710
Xie W-B et al (2013) Smad2 and MRTFB cooperatively regulate vascular smooth muscle differentiation from neural crest cells. Circ Res 113(8):p. https://doi.org/10.1161/CIRCRESAHA.113.301921
Carta L et al (2009) p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J Biol Chem 284(9):5630–5636
Thyberg J (1996) Differentiated properties and proliferation of arterial smooth muscle cells in culture. In: Jeon KW (ed) International review of cytology. Academic Press, Cambridge, pp 183–265
Ferruzzi J et al (2011) Mechanical assessment of elastin integrity in fibrillin-1-deficient carotid arteries: implications for Marfan syndrome. Cardiovasc Res 92(2):287–295
Li DY et al (1998) Elastin is an essential determinant of arterial morphogenesis. Nature 393:276
Nakamura T et al (2002) Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415:171
Spencer JA et al (2005) Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 102(8):2946
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Huang H et al (2006) Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun 351(2):321–327
Cheung C et al (2014) Modeling cerebrovascular pathophysiology in amyloid-β metabolism using neural-crest-derived smooth muscle cells. Cell Rep 9(1):391–401
Granata A et al (2016) An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death. Nat Genet 49:97
Dash Biraja C et al (2016) Tissue-engineered vascular rings from human iPSC-derived smooth muscle cells. Stem Cell Rep 7(1):19–28
Fernandez CE et al (2016) Human vascular microphysiological system for in vitro drug screening. Sci Rep 6:21579
Niklason LE et al (1999) Functional arteries grown in vitro. Science 284(5413):489
Quint C et al (2011) Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci USA 108(22):9214–9219
Gui L et al (2014) Construction of tissue-engineered small-diameter vascular grafts in fibrin scaffolds in 30 days. Tissue Eng Part A 20(9–10):1499–1507
Sundaram S et al (2014) Tissue-engineered vascular grafts created from human induced pluripotent stem cells. Stem Cells Transl Med 3(12):1535–1543
Atchison L et al (2017) A tissue engineered blood vessel model of Hutchinson–Gilford progeria syndrome using human iPSC-derived smooth muscle cells. Sci Rep 7(1):8168
Zhang P et al (2012) Inhibition of microRNA 29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels. Arterioscler Thromb Vasc Biol 32(3):756–759
Topouzis S, Majesky MW (1996) Smooth muscle lineage diversity in the chick embryo: two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-β. Dev Biol 178(2):430–445
Jaalouk DE, Lammerding J (2009) Mechanotransduction gone awry. Nat Rev Mol Cell Biol 10(1):63–73
Geiger B, Spatz JP, Bershadsky AD (2009) Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol 10:21
DuFort CC, Paszek MJ, Weaver VM (2011) Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol 12(5):308–319
Humphrey JD et al (2014) Dysfunctional mechanosensing in aneurysms. Science 344(6183):477
Guo D-C et al (2007) Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39:1488
Wang L et al (2010) Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet 87(5):701–707
Zhu L et al (2006) Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 38:343
Jiao Y et al (2017) Deficient circumferential growth is the primary determinant of aortic obstruction attributable to partial elastin deficiency. Arterioscler Thromb Vasc Biol 37(5):930–941
Pober BR, Johnson M, Urban Z (2008) Mechanisms and treatment of cardiovascular disease in Williams–Beuren syndrome. J Clin Investig 118(5):1606–1615
Urbán Z et al (2002) Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams–Beuren Syndrome. Am J Hum Genet 71(1):30–44
Kumar A et al (2016) Talin tension sensor reveals novel features of focal adhesion force transmission and mechanosensitivity. J Cell Biol 213(3):371
Jiang G et al (2006) Rigidity sensing at the leading edge through α(v)β(3) integrins and RPTPα. Biophys J 90(5):1804–1809
Jiao Y et al (2017) mTOR (mechanistic target of rapamycin) inhibition decreases mechanosignaling, collagen accumulation, and stiffening of the thoracic aorta in elastin-deficient mice. Arterioscler Thromb Vasc Biol 37(9):1657–1666
Gui L et al (2016) Implantable tissue-engineered blood vessels from human induced pluripotent stem cells. Biomaterials 102:120–129
Huang AH et al (2016) Biaxial stretch improves elastic fiber maturation, collagen arrangement, and mechanical properties in engineered arteries. Tissue engineering. Part C. Methods 22(6):524–533
Wanjare M, Agarwal N, Gerecht S (2015) Biomechanical strain induces elastin and collagen production in human pluripotent stem cell-derived vascular smooth muscle cells. Am J Physiol Cell Physiol 309(4):C271–C281
Tojais NF et al (2017) Co-dependence of BMPR2 and TGFβ in elastic fiber assembly and its perturbation in pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 37(8):1559–1569
Huang R et al (2006) Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 98(3):370
Jimenez F et al (2006) Ellagic and tannic acids protect newly synthesized elastic fibers from premature enzymatic degradation in dermal fibroblast cultures. J Investig Dermatol 126(6):1272–1280
Wu W, Allen RA, Wang Y (2012) Fast degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neo-artery. Nat Med 18(7):1148–1153
Luo J et al (2017) Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineering. Biomaterials 147:116–132
Del Monaco M et al (1997) Identification of novel glucocorticoid-response elements in human elastin promoter and demonstration of nucleotide sequence specificity of the receptor binding. J Investig Dermatol 108(6):938–942
Kähäri VM et al (1990) Deletion analyses of 5′-flanking region of the human elastin gene. Delineation of functional promoter and regulatory cis-elements. J Biol Chem 265(16):9485–9490
Sugitani H et al (2001) Nitric oxide stimulates elastin expression in chick aortic smooth muscle cells. Biol Pharm Bull 24(5):461–464
Wachi H et al (1995) Cell cycle-dependent regulation of elastin gene in cultured chick vascular smooth-muscle cells. Biochem J 309(2):575
Kucich U et al (2002) Transforming growth factor-β stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-δ, and p38. Am J Respir Cell Mol Biol 26(2):183–188
Marigo V et al (1994) Identification of a TGF-β responsive element in the human elastin promoter. Biochem Biophys Res Commun 199(2):1049–1056
Pierce RA, Kolodziej ME, Parks WC (1992) 1,25-Dihydroxyvitamin D3 represses tropoelastin expression by a posttranscriptional mechanism. J Biol Chem 267(16):11593–11599
Trapnell C et al (2010) Transcript assembly and abundance estimation from RNA-Seq reveals thousands of new transcripts and switching among isoforms. Nat Biotechnol 28(5):511–515
Chen F, Chisholm AD, Jin Y (2017) Tissue-specific regulation of alternative polyadenylation represses expression of a neuronal ankyrin isoform in C. elegans epidermal development. Development (Camb, Engl) 144(4):698–707
Xia Z et al (2014) Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types. Nat Commun 5:5274
Raz V et al (2018) The distinct transcriptomes of slow and fast adult muscles are delineated by noncoding RNAs. FASEB J 32(3):1579–1590
Ahmad Y et al (2012) Systematic analysis of protein pools, isoforms, and modifications affecting turnover and subcellular localization. Mol Cell Proteom 11(3):p. M111.013680
Dapas M et al (2017) Comparative evaluation of isoform-level gene expression estimation algorithms for RNA-seq and exon-array platforms. Brief Bioinform 18(2):260–269
Katz Y et al (2010) Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 7(12):1009–1015
Liu Y et al (2017) Impact of alternative splicing on the human proteome. Cell Rep 20(5):1229–1241
Cheung C et al (2012) Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol 30(2):165–173
Acknowledgements
We appreciate the support from Muhammad Riaz (Ph.D.) and Luke Batty (M.S.). This work was supported by NIH 1K02HL101990-01, 1R01HL116705-01, and Connecticut’s Regenerative Medicine Research Fund (CRMRF) 12-SCB-YALE-06 and 15-RMB-YALE-08 (all to Y.Q.). Work was also supported by an NIH Institutional Pre-Doctoral Pharmacology Training Program Fellowship T32-GM0007324 (M.E.) directed by Dr. Anton Bennett at Yale.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ellis, M.W., Luo, J. & Qyang, Y. Modeling elastin-associated vasculopathy with patient induced pluripotent stem cells and tissue engineering. Cell. Mol. Life Sci. 76, 893–901 (2019). https://doi.org/10.1007/s00018-018-2969-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-018-2969-7